Evidence map›Paper›PMID 31804555›Full record

ArticleScientific reports2019

Novel Bead-Based Epitope Assay is a sensitive and reliable tool for profiling epitope-specific antibody repertoire in food allergy.

Maria Suprun, Robert Getts, Rohit Raghunathan, Galina Grishina, Marc Witmer, Gustavo Gimenez, Hugh A Sampson, Mayte Suárez-Fariñas

Erratum issuedOpen access · goldAbstract readValidation Study
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Epitope-Specific IgE at 1 Year of Age Can Predict Peanut Allergy Status at 5 Years.International archives of allergy and immunology · 2023
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Evolution of epitope-specific IgE and IgGThe Journal of allergy and clinical immunology · 2021
    Trial
  7. Article
  8. Review
  9. Proteomic Applications in Vaccine Development.Advances in experimental medicine and biology · 2026
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. The future of food allergy diagnosis.Frontiers in allergy · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maria SuprunDepartment of Pediatrics, Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-9161-4021
Robert GettsAllerGenis LLC, Hatfield, PA, USA.
Rohit RaghunathanDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Galina GrishinaDepartment of Pediatrics, Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Marc WitmerAllerGenis LLC, Hatfield, PA, USA.
Gustavo GimenezDepartment of Pediatrics, Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Hugh A SampsonDepartment of Pediatrics, Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. hugh.sampson@mssm.edu.
Mayte Suárez-FariñasDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA. MayteSuarezFarinas@mssm.edu.ORCID http://orcid.org/0000-0001-8712-3553
Icahn School of Medicine at Mount Sinai · US

Funding

Mechanistic CoreU19AI066738 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI WOOD, ROBERT A · 2005 to 2016
$43.6M
Teaching biomedical and pharmacological trainees to produce FAIR data for AI & ML applicationsT32GM062754 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHLESSINGER, AVNER · 2001 to 2023
$6.2M
NIAID NIH HHS U19 AI066738NIGMS NIH HHS T32 GM062754
6 · The paper itself

Abstract

Identification of allergenic IgE epitopes is instrumental for the development of novel diagnostic and prognostic methods in food allergy. In this work, we present the quantification and validation of a Bead-Based Epitope Assay (BBEA) that through multiplexing of epitopes and multiple sample processing enables completion of large experiments in a short period of time, using minimal quantities of patients' blood. Peptides that are uniquely coupled to beads are incubated with serum or plasma samples, and after a secondary fluorophore-labeled antibody is added, the level of fluorescence is quantified with a Luminex reader. The signal is then normalized and converted to epitope-specific antibody binding values. We show that the effect of technical artifacts, i.e. well position or reading order, is minimal; and batch effects - different individual microplate runs - can be easily estimated and eliminated from the data. Epitope-specific antibody binding quantified with BBEA is highly reliable, reproducible and has greater sensitivity of epitope detection compared to peptide microarrays. IgE directed at allergenic epitopes is a sensitive biomarker of food allergy and can be used to predict allergy severity and phenotypes; and quantification of the relationship between epitope-specific IgE and IgG4 can further improve our understanding of the immune mechanisms behind allergic sensitization.

Indexed as

AdolescentAdultAllergensAnimalsArachisBiological Variation, IndividualChildEpitope MappingEpitopesFemaleFood HypersensitivityHigh-Throughput Screening AssaysHumansImmunoglobulin EMaleMilkAllergensEpitopesImmunoglobulin EPeptide Library

Identifiers

PMID31804555
PMCPMC6895130
OpenAlexW2993471499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.